European Growth Companies With Insider Ownership Up To 25%

As European markets experience a positive upswing, with the STOXX Europe 600 Index climbing 2.77% amid easing trade tensions, investors are keenly observing growth companies that demonstrate resilience and potential in this evolving landscape. A key factor that often signals strong alignment between company management and shareholder interests is high insider ownership, which can be particularly appealing in times of economic uncertainty as it may indicate confidence in the company's future prospects.

Top 10 Growth Companies With High Insider Ownership In Europe

Click here to see the full list of 207 stocks from our Fast Growing European Companies With High Insider Ownership screener.

We're going to check out a few of the best picks from our screener tool.

Pharmanutra (BIT:PHN)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Pharmanutra S.p.A. is a pharmaceutical and nutraceutical company that focuses on researching, designing, developing, and marketing nutritional supplements and medical devices across various regions including Italy, Europe, the Middle East, South America, the Far East, and internationally; it has a market capitalization of €516.65 million.

Operations: The company's revenue is derived from segments including €5.92 million from Akern, €70.24 million from Italy, and €39.34 million from foreign markets.

Insider Ownership: 10.8%

Pharmanutra demonstrates strong growth potential with insider ownership aligning interests. Its revenue is forecast to grow at 10.9% annually, outpacing the Italian market. Earnings are expected to rise by 14.6% per year, significantly above market averages, and past earnings grew by 29.4%. Recent substantial insider buying indicates confidence in its future prospects. Analysts predict a stock price increase of over 50%, supported by high projected return on equity of 27.3% in three years.

• Click here to discover the nuances of Pharmanutra with our detailed analytical future growth report.
• Our comprehensive valuation report raises the possibility that Pharmanutra is priced higher than what may be justified by its financials.

Scandi Standard (OM:SCST)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Scandi Standard AB (publ) operates in the production and sale of chilled, frozen, and ready-to-eat chicken products across several countries including Sweden, Norway, Ireland, Denmark, Finland, Germany, the United Kingdom and internationally with a market cap of SEK5.76 billion.

Operations: Scandi Standard generates revenue through the sale of chilled, frozen, and ready-to-eat chicken products across Sweden, Norway, Ireland, Denmark, Finland, Germany, the United Kingdom, and other international markets.

Insider Ownership: 17.4%

Scandi Standard shows potential with forecasted annual earnings growth of 21.1%, outpacing the Swedish market, despite a low return on equity projection of 13.7%. The company trades at a significant discount to its estimated fair value, suggesting possible undervaluation. Recent earnings reported sales of SEK 3.38 billion for Q1 2025, up from SEK 3.16 billion year-on-year, but net income slightly declined to SEK 66 million from SEK 70 million.

• Dive into the specifics of Scandi Standard here with our thorough growth forecast report.
• Our valuation report unveils the possibility Scandi Standard's shares may be trading at a discount.

Verve Group (XTRA:M8G)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Verve Group SE is a digital media company that provides ad-software solutions in North America and Europe, with a market cap of €631.95 million.

Operations: The company's revenue is derived from Demand Side Platforms (DSP) at €100.55 million and Supply Side Platforms (SSP) at €390.27 million.

Insider Ownership: 25.8%

Verve Group SE demonstrates potential with a forecasted annual earnings growth of 28.6%, surpassing the German market's average. Despite trading at a substantial discount to its estimated fair value, recent results show declining profit margins and shareholder dilution over the past year. The company anticipates robust double-digit organic growth for 2025, driven by ID-less solutions and a strong U.S. advertising market, while insiders have increased their holdings significantly in recent months.

• Click to explore a detailed breakdown of our findings in Verve Group's earnings growth report.
• Our expertly prepared valuation report Verve Group implies its share price may be lower than expected.

Key Takeaways

• Discover the full array of 207 Fast Growing European Companies With High Insider Ownership right here.
• Interested In Other Possibilities? The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 26 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com